Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 2:2021:2531062.
doi: 10.1155/2021/2531062. eCollection 2021.

Oxidative Stress Genes in Diabetes Mellitus Type 2: Association with Diabetic Kidney Disease

Affiliations

Oxidative Stress Genes in Diabetes Mellitus Type 2: Association with Diabetic Kidney Disease

Athanasios Roumeliotis et al. Oxid Med Cell Longev. .

Abstract

Diabetic type 2 patients compared to nondiabetic patients exhibit an increased risk of developing diabetic kidney disease (DKD), the leading cause of end-stage renal disease. Hyperglycemia, hypertension, oxidative stress (OS), and genetic background are some of the mechanisms and pathways implicated in DKD pathogenesis. However, data on OS pathway susceptibility genes show limited success and conflicting or inconclusive results. Our study is aimed at exploring OS pathway genes and variants which could be associated with DKD. We recruited 121 diabetes mellitus type 2 (DM2) patients with DKD (cases) and 220 DM2, non-DKD patients (control) of Greek origin and performed a case-control association study using genome-wide association data. PLINK and EIGENSOFT were used to analyze the data. Our results indicate 43 single nucleotide polymorphisms with their 21 corresponding genes on the OS pathway possibly contributing or protecting from DKD: SPP1, TPO, TTN, SGO2, NOS3, PDLIM1, CLU, CCS, GPX4, TXNRD2, EPHX2, MTL5, EPX, GPX3, ALOX12, IPCEF1, GSTA, OXR1, GPX6, AOX1, and PRNP. Therefore, a genetic OS background might underlie the complex pathogenesis of DKD in DM2 patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Zimmet P., Alberti K. G., Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–787. doi: 10.1038/414782a. - DOI - PubMed
    1. Monti M. C., Lonsdale J. T., Montomoli C., Montross R., Schlag E., Greenberg D. A. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. The Journal of Clinical Endocrinology and Metabolism. 2007;92(12):4650–4655. doi: 10.1210/jc.2007-1185. - DOI - PubMed
    1. Dounousi E., Duni A., Leivaditis K., Vaios V., Eleftheriadis T., Liakopoulos V. Improvements in the management of diabetic nephropathy. The Review of Diabetic Studies: RDS. 2015;12(1-2):119–133. doi: 10.1900/RDS.2015.12.119. - DOI - PMC - PubMed
    1. Yamagishi S., Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxidative Medicine and Cellular Longevity. 2010;3(2):108. doi: 10.4161/oxim.3.2.11148. - DOI - PMC - PubMed
    1. Duni A., Liakopoulos V., Roumeliotis S., Peschos D., Dounousi E. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne's thread. International Journal of Molecular Sciences. 2019;20(15) doi: 10.3390/ijms20153711. - DOI - PMC - PubMed

MeSH terms